EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 29 / Numéro 8-9 (Août–Septembre 2013) Med Sci (Paris), 29 8-9 (2013) 800-806 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 8-9, Août–Septembre 2013
Page(s) 800 - 806
Section Diabète : approches thérapeutiques émergentes
DOI https://doi.org/10.1051/medsci/2013298021
Publié en ligne 5 septembre 2013
  1. Knoll AH, Barghoorn ES. Archean microfossils showing cell division from the swaziland system of South Africa. Science 1977 ; 198 : 396–398. [CrossRef] [PubMed] [Google Scholar]
  2. Donoghue PC, Antcliffe JB. Early life. Origins of multicellularity. Nature 2010 ; 466 : 41–42. [CrossRef] [PubMed] [Google Scholar]
  3. Payne JL, Boyer AG, Brown JH, et al. Two-phase increase in the maximum size of life over 3.5 billion years reflects biological innovation and environmental opportunity. Proc Natl Acad Sci USA 2009 ; 106 : 24–27. [CrossRef] [Google Scholar]
  4. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012 ; 336 : 1262–1267. [CrossRef] [PubMed] [Google Scholar]
  5. Sagan L. On the origin of mitosing cells. J Theor Biol 1967 ; 14 : 255–274. [CrossRef] [PubMed] [Google Scholar]
  6. Gray MW, Burger G, Lang BF., The origin early evolution of mitochondria. Genome Biol 2001 ; 2 : 1018. [Google Scholar]
  7. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010 ; 87 : 4–14. [CrossRef] [PubMed] [Google Scholar]
  8. Holmes E, Kinross J, Gibson GR, et al. Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 2012 ; 4 : 137 rv 136. [CrossRef] [Google Scholar]
  9. Caesar R, Fak F, Backhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 2010 ; 268 : 320–328. [CrossRef] [PubMed] [Google Scholar]
  10. Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006 ; 21 : 517–523. [CrossRef] [PubMed] [Google Scholar]
  11. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009 ; 457 : 480–484. [CrossRef] [PubMed] [Google Scholar]
  12. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004 ; 101 : 15718–15723. [CrossRef] [PubMed] [Google Scholar]
  13. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 ; 444 : 1027–1031. [CrossRef] [PubMed] [Google Scholar]
  14. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 ; 464 : 59–65. [CrossRef] [PubMed] [Google Scholar]
  15. Turnbaugh P, Ridaura V, Faith J, et al. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009 ; 1 : 6–14. [CrossRef] [Google Scholar]
  16. Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012 ; 150 : 470–480. [CrossRef] [PubMed] [Google Scholar]
  17. Biagi E, Candela M, Fairweather-Tait S, et al. Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 2012 ; 34 : 247–267. [CrossRef] [PubMed] [Google Scholar]
  18. Barrett E, Guinane CM, Ryan CA, et al. Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants. Microbiology Open 2013 ; 2 : 215–225. [CrossRef] [Google Scholar]
  19. Azad MB, Konya T, Maughan H, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013 ; 185 : 385–394. [CrossRef] [PubMed] [Google Scholar]
  20. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005 ; 102 : 11070–11075. [CrossRef] [Google Scholar]
  21. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012 ; 490 : 55–60. [CrossRef] [PubMed] [Google Scholar]
  22. Serino M, Fernandez-Real JM, Fuentes EG, et al. The gut microbiota profile is associated with insulin action in humans. Acta Diabetol 2012 ; DOI : 10.1007/s00592-012-0410-5 [Google Scholar]
  23. Amar J, Chabo C, Waget A, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011 ; 3 : 559–572. [CrossRef] [PubMed] [Google Scholar]
  24. Amar J, Serino M, Lange C, et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011 ; 54 : 3055–3061. [CrossRef] [PubMed] [Google Scholar]
  25. Amar J, Lange C, Payros G, et al. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the DESIR study group. PLoS One 2013 ; 8 : e54461. [CrossRef] [PubMed] [Google Scholar]
  26. Bouloumie A, Casteilla L, Lafontan M. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first? Arterioscler Thromb Vasc Biol 2008 ; 28 : 1211–1213. [CrossRef] [PubMed] [Google Scholar]
  27. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab 2009 ; 35 : 251–260. [CrossRef] [PubMed] [Google Scholar]
  28. Amar J, Burcelin R, Ruidavets JB, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008 ; 87 : 1219–1223. [CrossRef] [PubMed] [Google Scholar]
  29. Pendyala S, Walker J, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012 ; 142 : 1100–1101. [CrossRef] [PubMed] [Google Scholar]
  30. Moreira AP, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012 ; 108 : 801–809. [CrossRef] [PubMed] [Google Scholar]
  31. Fiorini RN, Shafizadeh SF, Polito C, et al. Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice. Am J Transplant 2004 ; 4 : 1567–1573. [CrossRef] [PubMed] [Google Scholar]
  32. Pappo I, Becovier H, Berry EM, Freund HR. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 1991 ; 51 : 106–112. [CrossRef] [PubMed] [Google Scholar]
  33. Chen F, Liu Y, Zhu H, et al. Fish oil attenuates liver injury caused by LPS in weaned pigs associated with inhibition of TLR4 and nucleotide-binding oligomerization domain protein signaling pathways. Innate Immun 2013 ; DOI : 10.1177/1753425912472003 [Google Scholar]
  34. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008 ; 57 : 1470–1481. [CrossRef] [PubMed] [Google Scholar]
  35. Burcelin R, Luche E, Serino M, Amar J. The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases? Front Biosci 2009 ; 14 : 5107–5117. [CrossRef] [Google Scholar]
  36. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 2013 ; 110 : 4410–4415. [CrossRef] [Google Scholar]
  37. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011 ; 108 : 4592–4598. [CrossRef] [Google Scholar]
  38. Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of Tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013 ; 17 : 225–235. [CrossRef] [PubMed] [Google Scholar]
  39. Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008 ; 455 : 1109–1113. [CrossRef] [PubMed] [Google Scholar]
  40. Markle JG, Frank DN, Mortin-Toth S, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013 ; 339 : 1084–1088. [CrossRef] [PubMed] [Google Scholar]
  41. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012 ; 336 : 1268–1273. [CrossRef] [PubMed] [Google Scholar]
  42. Ivanov, II, Frutos Rde L, Manel N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008 ; 4 : 337–349. [CrossRef] [PubMed] [Google Scholar]
  43. Burcelin R, Garidou L, Pomie C. Immuno-microbiota cross and talk: The new paradigm of metabolic diseases. Semin Immunol 2012 ; 24 : 67–74. [CrossRef] [PubMed] [Google Scholar]
  44. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011 ; 141 : 599–609. [CrossRef] [PubMed] [Google Scholar]
  45. Diaz Heijtz R, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011 ; 108 : 3047–3052. [CrossRef] [PubMed] [Google Scholar]
  46. Neufeld KA, Kang N, Bienenstock J, Foster JA. Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 2011 ; 4 : 492–494. [CrossRef] [PubMed] [Google Scholar]
  47. Reinhardt C, Bergentall M, Greiner TU, et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 2012 ; 483 : 627–631. [CrossRef] [PubMed] [Google Scholar]
  48. Carrière A, Jeanson Y, Cousin B, et al. Le recrutement et l’activation d’adipocytes bruns et/ou BRITE : une perspective réelle pour le traitement des maladies métaboliques. Med Sci (Paris) 2013 ; 29 : 729–735. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. Normand S, Secher T, Chamaillard M. La dysbiose, une nouvelle entité en médecine ? Med Sci (Paris) 2013 ; 29 : 586–589. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.